Abstract
Peptidylglycine monooxygenase (PHM) is a copper-dependent enzyme that catalyzes C-alpha hydroxylation of glycine extended pro-peptides, a critical post-translational step in peptide hormone processing. The canonical mechanism posits that dioxygen binds at the mononuclear M-center to generate a Cu(II)-superoxo species capable of H-atom abstraction from the peptidyl substrate, followed by long range ET from the CuH center. Recent crystallographic and biochemical data has challenged this mechanism, suggesting instead that an “open-to-closed” transition brings the copper centers closer allowing reactivity within a binuclear intermediate. Here we present the first direct observation of an enzyme-bound binuclear copper species, captured by use of an Ala-Ala-Phe-hCys inhibitor complex. This molecule reacts with the fully reduced enzyme to form a thiolate-bridged binuclear species characterized by EXAFS of the WT and its M314H variant, and with the oxidized enzyme to form a novel mixed valence entity characterized by UV/Vis, and EPR. Mechanistic implications are discussed.
Graphical Abstract

Copper monooxygenases play important roles in human health and climate mitigation.1–5 Peptidylglycine monooxygenase (PHM) catalyzes the post-translational amidation of neuropeptide hormones,6–8 using two copper atoms, CuH and CuM, which are ligated to three histidines (H) and two histidines and a methionine (M). Early structures showed the copper atoms separated by ~ 11 Å across a solvent-filled cleft, and a substrate (di-iodo-YG) bound by its carboxy terminus to residues R240 and Y318 (Scheme 1).9–10 An oxygen adduct bound to CuM was also captured, but with the O2 in an unproductive conformation pointing away from the substrate.11 These structures, together with spectroscopic12–16, kinetic1, 17–21 and computational22–26 contributions led to the current canonical mechanism in which the substrate-bound di-Cu(I) enzyme reacts with dioxygen forming a Cu(II)M-superoxo intermediate which subsequently abstracts a H atom at the glycyl C-alpha to form the substrate radical. Long-range electron tunneling (ET) completes the catalytic cycle with the electron being supplied either directly from CuH or via a Cu(II)M-oxyl intermediate.
Scheme 1.

Top Active site structure of PHM (pdb 3PHM) showing positioning of a dipeptide substrate bound via its carboxy terminus to Y318 and R240. Bottom, mixed valence formulation of the PHM-Alo-Alo-Phe-hcys complex.
Recent insights have given cause to reconsider this mechanism.2 In particular, new crystal structures for PHM27–28 and its sister enzyme dopamine β-monooxygenase (DBM)29 show the enzymes in “fully open” (Cu-Cu = 14 Å) and “closed” conformations (Cu-Cu = 4 – 5 Å). The structures suggest flexible dynamics of the two sub-domains allowing the Cu-Cu distance to vary continuously.28 Reformulation of the mechanism to include a binuclear Cu intermediate as proposed from the DBM structure29 and from a recent QM/MM study26 is therefore timely. Here we describe a complex of PHM with a peptide inhibitor complex which establishes the accessibility of a binuclear state.
We reasoned that a substrate analogue bound near CuM (Scheme 1 bottom) might capture the closed state if it carried a Cu(I)-binding functionality capable of bridging the two coppers. We chose the peptidyl inhibitor Ala-Ala-Phe-homocysteine (AAF-hCys) known to form a strong complex with the enzyme30 where binding should occur both via the C-terminal carboxylate and via additional coordination of the thiol to copper (Scheme 1). If binding to both coppers is observed, it would show that a conformation exists with the two Cus in a closed complex, allowing a ligand such as O2 to bridge and do chemistry. AAF-hCys was prepared by solid phase peptide synthesis. The hCys-containing peptide is largely in the thiol form, and exhibits an m/z of 425.19, which is within 3.29 ppm of expected (Fig. S1).
First, we examined the reaction of AAF-hCys with the fully reduced PHM using EXAFS spectroscopy (Figure 1). The intensity of the Cu-S scattering peak in the FT grew significantly relative to the unligated reduced enzyme (Fig. S2 and Table S2 fit 1), and required simulation by 1.5 Cu-S at 2.27 Å with a Debye Waller (DW) of 0.006 Å2 (Fig. 1 (a) and Table S2 fit 2). This result suggests that in addition to the CuM-S(Met314) interaction (0.5 Cu-S per Cu), both coppers now form one additional bond each to the thiolate ligand implying a mono-thiolate bridge. The correlation between coordination number and DW factor introduces uncertainty into the Cu-S shell occupancy, and a reasonable fit could be obtained with 1 Cu-S with a DW of 0.002 Å2 (Table S2 fit 5). However, when the S shell was split into Cu-S(thiolate) and Cu-S(met) components and the measured DW of the Cu-S(Met) shell in the reduced WT enzyme (0.012 Å2, Table S2, fit 1) fixed in the simulation, the Cu-S(thiolate) refined to 1.0 S per Cu with a DW of 0.004 Å2 (Table S2 fit 3). Furthermore, limits can be put on Cu-S(thiolate) DW factors from other studies that have established values >0.010 A2 for Cu-S(Met) interactions31–34, and values of >0.005 Å2 for Cu-S(thiolate) in mixed histidine/cysteine containing systems.35 Specifically, the DW factor (2σ2) for the homocysteine analogue of azurin36 (C112hCys) is 0.006 Å2 while that of the bridging thiolates of CuA type sites33 is >0.009 Å2. Thus, a value of 0.006 Å2 is close to the lower limit expected for mixed His/Met/Cys or hCys coordination providing validation of the bridged thiolate interpretation. Parameters used to construct these fits are listed in Table S237.
Figure 1.

Fourier transforms and k3-weighted EXAFS (insets) for the reaction between PHM and AAF-hCys. Experimental (black) versus simulated (red) spectra for the Cu K edge of (a) the AAF-hCys complex of ascorbate-reduced WT PHM (b) the AAF-hCys complex of ascorbate-reduced M314H simulated with 1S per Cu and (c) the AAF-hCys complex of ascorbate-reduced M314H simulated with 0.5 S per Cu. Metrical details extracted from the simulations are listed in Table S2.
To remove ambiguities associated with the presence of the M314 sulfur ligand, we carried out an identical reaction with the M314H derivative which lacks the coordinating Met ligand. The ascorbate-reduced protein gave an EXAFS spectrum (Fig. 1(b)) with the same intense S wave now simulating to 1.0 Cu-S at 2.23 Å with a DW factor (0.006 Å2) similar to the WT protein (Table S2 fit 9). Simulations that restricted the shell occupancy to 0.5 (expected for non-bridging thiolate coordination) were completely inadequate (Fig. 1(c) and Table S2, fit 10). This result confirms the assignments made for the WT protein and establishes that the thiol must bridge the two Cu atoms in a binuclear configuration.
Next we examined the reaction chemistry of AAF-hCys with the fully oxidized PHM. Binding of ~2.5 equivalents elicited a purple species with broad intense absorption at 925 nm (estimated ε = ~1300 M−1 cm−1) and weaker bands at 580 and 460 nm (Fig. 2). The 925 nm feature is characteristic of intervalence charge transfer transitions (IVCT) of a mixed-valence (MV) center such as the valence localized (class II) halide complexes of hemocyanin 38 or the valence delocalized (class III) centers of CuA of cytochrome oxidase and N2O reductase 39–45 These two classes can be distinguished by their copper hyperfine patterns in the EPR spectra, where class II give rise to 4-line patterns and class III exhibit 7-line patterns, the latter due to additional splittings arising from strong coupling of the electron spin to both copper nuclear spins. EPR spectroscopy (Fig. 3) of the PHM MV complex confirmed that ~30% of the copper was undetectable while reaction with ascorbate led to an immediate further reduction in intensity to 35% of the original oxidized enzyme with no loss of color in the first 3 minutes. These data are consistent with the initial presence of a mixture of MV and an oxidized PHM species in a ~65:35 ratio46. Serendipitously, while the residual oxidized species is rapidly reduced by ascorbate, reduction of the MV species is slow (Fig. S3), allowing it to be observed in the EPR of the 3-minute ascorbate-reduced sample with no interference from any residual oxidized PHM species (Fig. 3 and Fig. S4). Simulation using EASYSPIN47 suggests that the unpaired spin is localized at low temperature since the spectrum shows a 4- rather than 7-line pattern in the parallel region (Fig. 3 top panel and Fig. S4 and Table S1 fit 1). The species remaining after 3-min ascorbate reduction is best described by a 2-component system in a 3:1 ratio, with the major component giving g and A values consistent with a Cu(II)-thiolate species (g3 = 2.21, A3 = 389 MHz)35, and the minor component (g3 = 2.30, A3 = 393 MHz) more characteristic of mixed O/N coordination. Inclusion of Cu-Cu nuclear interaction did not improve the simulation (Table S1 fit 2, and Fig. S4). The data are consistent with a MV thiolate-bridged binuclear species as shown in Scheme 1 exhibiting localized class II behavior at low temperature. Whereas the UV/vis data suggest that the Cu(II) component of the MV complex is type 1-like with weak S to Cu(II) CT at 460 nm, and stronger S to Cu(II) at 580 nm, the EPR spectra are more typical of a “green” or “red” than a “blue” copper site 35. These preliminary assignments are supported by EXAFS of the MV species which shows a long Cu-S distance of 2.28 Å (Fig. S5, Table S2 fit 11).
Figure 2.

Titration of fully oxidized PHM with Ala-Ala-Phe-hCys.
Figure 3.

EPR spectra of WT PHM titrated with AAF-hCys. Bottom panel: (a) WT oxidized PHM (blue); (b) WT + 3 equivalents AAF-hCys (pink); (c) 3 minute reduction by 5 mM ascorbate (green), and (d) 20 minute reduction by 5 mM ascorbate (black). Top panel: Simulation of the 3 minute reduced sample using Easyspin. Best fit (Fit 1 Table S1) was a 2-component system in a 1 : 0.35 ratio.
The NIR band observed in the PHM-AAF-hCys complex is typical of an IVCT were one copper is in the Cu(II) state and the other in the Cu(I) state. These IVCTs arise from transitions from a doubly occupied HOMO centered on the Cu(I) center to a singly occupied LUMO centered on the Cu(II) center. Under the Robin-Day classification, class II MV complexes arise from weakly coupled binuclear sites with a thermal barrier to intersite ET, and class III from strongly coupling sites with the coupling energy HAB > the reorganizational energy λ, and a low to non-existent thermal barrier for intersite ET48. Both class II and class III systems require a ligand bridge to couple the two metal centers. Examples of class II includes the halide-bridged complexes of half-met hemocyanin38 while class III includes the CuA site of cytochrome oxidase 40, 43–44, 49, N2O reductase42, 50, purple copper azurin51–52, pMMOD53 and a bis-thiolato dicopper model.43, 45 Class III complexes exhibit intersite ET rates that are fast on the timescale of electronic transitions, resulting in full delocalization of the unpaired electron over both metal centers. Class II systems on the other hand have slower rates of ET and often show a temperature dependence due to the thermal barrier54.
The class II behavior observed for PHM suggests that the bridging thiol provides weak coupling between the H and M centers, insufficient to overcome the reorganizational barrier to bringing the cupric center into a Cu(I)-favorable state, likely arising from the chemical inequivalence of the H and M centers. We note that class III to class II interconversion has been observed due to ligand set perturbation of the CuA center of purple copper azurin 55. Notwithstanding, the IVCT provides strong confirmatory evidence that the binding of the AAF-hCys peptide induces the closed conformation and, when considered alongside the EXAFS data showing thiolate bridging in the fully reduced state, provides compelling evidence for a binuclear state.
The stability of the MV state as evidenced by its slow reduction is notable. Wang and coworkers have proposed a reaction mechanism for DBM (and by inference PHM20) from QM/MM calculations involving a MV binuclear intermediate with lower activation energy for H-atom abstraction than its mononuclear analogue26 (Scheme 2). Our current work suggests that reaction chemistry leading to such a species is accessible.
Scheme 2.

Proposed mixed valence intermediate adapted from reference 26
A binuclear mechanism could explain many experimental findings that are inconsistent with the canonical mononuclear mechanism. In addition to structural evidence for sub-domain dynamics2, 27–29, the following observations can be cited. First, mononuclear protein models of the CuM site in aqueous solution show sluggish reactivity towards O231 despite demonstrated stability of inorganic Cu(II)-superoxo complexes in organic solvents at low temperature;56–67 second, ν(CO) for the CuM-CO complex is red shifted by 30 cm−1 in the presence of substrate reminiscent of the semi-bridged carbonyls of bi- or hetero-bimetallic sites2, 15, 68–69; third, substrate binding is always coupled to product hydroxylation establishing a requirement for substrate activation2; and fourth, substrate hydroxylation from oxidized enzyme and hydrogen peroxide is viable and catalytic, but leads to approximately 60 percent ambient 16O exchange when H218O2 is used as the oxygen source70. This requires an intermediate where Cu(II)-peroxide can equilibrate with Cu(I)-dioxygen, also suggestive of a binuclear state. Our future efforts will be directed towards generating binucleating substrate-analogues that bring us closer to illuminating these important questions.
Supplementary Material
ACKNOWLEDGMENT
Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02–76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (P30GM133894).
Funding Sources:
This work was supported by NIGMS 1R35GM136239 (to N.J.B.), NIGMS R35GM126956 (to V.B.), and NIH T32-GM122740 (to K.A.S.E.).
ABBREVIATIONS
- ET
electron transfer
- PHM
peptidylglycine monooxygenaase
- DBM
dopamine β-monooxygenase
- AAF-hCys
Ala-Ala-Phe-homocysteine
- MS
mass spectrometry
- MV
mixed-valence
- DW
Debye-Waller factor
- IVCT
intervalence charge transfer
Footnotes
ASSOCIATED CONTENT
Supporting Information.
5 Figures of data and 2 Tables describing MS purification of peptide, reduction of the MV species by ascorbate, EPR and EXAFS simulations and Tables of parameters used in the spectral simulations. This material is available free of charge via the Internet at http://pubs.acs.org.
Protein Accession Number (FASTA)
CAA42210.1 peptidylglycine alpha-amidating monooxygenase [Rattus norvegicus]
MAGRARSGLLLLLLGLLALQSSCLAFRSPLSVFKRFKETTRSFSNECLGTIGPVTPLDASDFALDIRMPGVTPKESDTYFCMSMRLPVDEEAFVIDFKPRASMDTVHHMLLFGCNMPSSTGSYWFCDEGTCTDKANILYAWARNAPPTRLPKGVGFRVGGETGSKYFVLQVHYGDISAFRDNHKDCSGVSVHLTRVPQPLIAGMYLMMSVDTVIPPGEKVVNADISCQYKMYPMHVFAYRVHTHHLGKVVSGYRVRNGQWTLIGRQNPQLPQAFYPVEHPVDVTFGDILAARCVFTGEGRTEATHIGGTSSDEMCNLYIMYYMEAKYALSFMTCTKNVAPDMFRTIPAEANIPIPV
References
- 1.Klinman JP, The copper-enzyme family of dopamine b -monooxygenase and peptidylglycine a -hydroxylating monooxygenase: Resolving the chemical pathway for substrate hydroxylation. J. Biol. Chem. 2006, 281, 3013–3016. [DOI] [PubMed] [Google Scholar]
- 2.Welch EF; Rush KW; Arias RJ; Blackburn NJ, Copper monooxygenase reactivity: Do consensus mechanisms accurately reflect experimental observations? J Inorg Biochem 2022, 231, 111780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Koo CW; Rosenzweig AC, Biochemistry of aerobic biological methane oxidation. Chem Soc Rev 2021, 50 (5), 3424–3436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ipsen JO; Hallas-Moller M; Brander S; Lo Leggio L; Johansen KS, Lytic polysaccharide monooxygenases and other histidine-brace copper proteins: structure, oxygen activation and biotechnological applications. Biochem. Soc. Trans. 2021, 49 (1), 531–540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Schroder GC; O’Dell WB; Webb SP; Agarwal PK; Meilleur F, Capture of activated dioxygen intermediates at the copper-active site of a lytic polysaccharide monooxygenase. Chemical science 2022, 13 (45), 13303–13320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kumar D; Mains RE; Eipper E, 60 YEARS OF POMC: From POMC and alphaMSH to PAM, molecular oxygen, copper and vitamin C. Journal of molecular endocrinology 2016, 56 T63–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Merkler DJ; Hawley AJ; Eipper BA; Mains RE, Peptidylglycine alpha-amidating monooxygenase as a therapeutic target or biomarker for human diseases. Br J Pharmacol 2022, 179, 3306–3324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Prigge ST; Mains RE; Eipper BA; Amzel LM, New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell. Mol. Life Sci. 2000, 57, 1236–1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Prigge ST; Kolhekar AS; Eipper BA; Mains RE; Amzel LM, Amidation of bioactive peptides: the structure of peptidylglycine a-hydroxylating monooxygenase. Science 1997, 278, 1300–1305. [DOI] [PubMed] [Google Scholar]
- 10.Prigge ST; Kolhekar AS; Eipper BA; Mains RE; Amzel LM, Substrate-mediated electron transfer in peptidylglycine a-hydroxylating monooxygenase. Nature Struct. Biol. 1999, 6, 976–983. [DOI] [PubMed] [Google Scholar]
- 11.Prigge ST; Eipper BA; Mains RE; Amzel LM, Dioxygen binds end-on to mononuclear copper in a precatalytic enzyme complex. Science 2004, 304 (5672), 864–867. [DOI] [PubMed] [Google Scholar]
- 12.Blackburn NJ; Rhames FC; Ralle M; Jaron S, Major changes in copper coordination accompany reduction of peptidylglycine monooxygenase: implications for electron transfer and the catalytic mechanism. Journal of Biological Inorganic Chemistry 2000, 5 (3), 341–353. [DOI] [PubMed] [Google Scholar]
- 13.Boswell JS; Reedy BJ; Kulathila R; Merkler DJ; Blackburn NJ, Structural investigations on the coordination environment of the active-site copper centers of recombinant bifunctional peptidylglycine a-amidating enzyme. Biochemistry 1996, 35, 12241–12250. [DOI] [PubMed] [Google Scholar]
- 14.Chen P; Bell J; Eipper BA; Solomon EI, Oxygen activation by the noncoupled binuclear copper site in peptidylglycine a-hydroxylating monooxygenase. Spectroscopic definition of the resting sites and the putative CuIIM-OOH intermediate. Biochemistry 2004, 43 (19), 5735–47. [DOI] [PubMed] [Google Scholar]
- 15.Jaron S; Blackburn NJ, Does superoxide channel between the copper centers in peptidylglycine monooxygenase? A new mechanism based on carbon monoxide reactivity. Biochemistry 1999, 38, 15086–15096. [DOI] [PubMed] [Google Scholar]
- 16.Martin-Diaconescu V; Chacon KN; Delgado-Jaime MU; Sokaras D; Weng TC; DeBeer S; Blackburn NJ, Kb Valence to core X-ray emission studies of Cu(I) binding proteins with mixed methionine - histidine coordination. Relevance to the reactivity of the M- and H-sites of peptidylglycine monooxygenase. Inorg. Chem. 2016, 55 (7), 3431–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Evans JP; Ahn K; Klinman JP, Evidence that dioxygen and substrate activation are tightly coupled in dopamine b -monooxygenase: Implications for oxygen activation. J. Biol. Chem. 2003, 278, 49691–49698. [DOI] [PubMed] [Google Scholar]
- 18.Evans JP; Blackburn NJ; Klinman JP, The catalytic role of the copper ligand H172 of peptidylglycine a-hydroxylating monooxygenase: a kinetic study of the H172A mutant. Biochemistry 2006, 45, 15419–15429. [DOI] [PubMed] [Google Scholar]
- 19.Francisco WA; Knapp MJ; Blackburn NJ; Klinman JP, Hydrogen tunneling in peptidylglycine a-hydroxylating monooxygenase. J. Am. Chem. Soc. 2002, 124, 8194 – 8195. [DOI] [PubMed] [Google Scholar]
- 20.Francisco WA; Merkler DJ; Blackburn NJ; Klinman JP, Kinetic mechanism and intrinsic isotope effects for the peptidylglycine a-amidating enzyme reaction. Biochemistry 1998, 37, 8244–8252. [DOI] [PubMed] [Google Scholar]
- 21.Klinman JP, Mechanisms whereby mononuclear copper proteins functionalize organic substrates. Chem. Rev. 1996, 1996, 2541–2561. [DOI] [PubMed] [Google Scholar]
- 22.Chen P; Solomon EI, Oxygen activation by the noncoupled binuclear copper site in peptidylglycine a-hydroxylating monooxygenase. Reaction mechanism and role of the noncoupled nature of the active site. J. Am. Chem. Soc. 2004, 126 (15), 4991–5000. [DOI] [PubMed] [Google Scholar]
- 23.Chen P; Solomon EI, O2 activation by binuclear Cu sites: noncoupled versus exchange coupled reaction mechanisms. Proc. Natl. Acad. Sci. U S A 2004, 101 (36), 13105–13110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Cowley RE; Tian L; Solomon EI, Mechanism of O2 activation and substrate hydroxylation in noncoupled binuclear copper monooxygenases. Proc. Natl. Acad. Sci. USA 2016, 113 (43), 12035–12040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Crespo A; Marti MA; Roitberg AE; Amzel LM; Estrin DA, The catalytic mechanism of peptidylglycine a-hydroxylating monooxygenase investigated by computer simulation. J. Am. Chem. Soc. 2006, 128 (39), 12817–28. [DOI] [PubMed] [Google Scholar]
- 26.Wu P; Fan F; Song J; Peng W; Liu J; Li C; Cao Z; Wang B, Theory demonstrated a “coupled” mechanism for O2 activation and substrate hydroxylation by binuclear copper monooxygenases. J. Am. Chem. Soc. 2019, 141 (50), 19776–19789. [DOI] [PubMed] [Google Scholar]
- 27.Maheshwari S; Shimokawa C; Rudzka K; Kline CD; Eipper BA; Mains RE; Gabelli SB; Blackburn N; Amzel LM, Effects of copper occupancy on the conformational landscape of peptidylglycine a-hydroxylating monooxygenase. Commun. Biol. (Nature Publishing) 2018, 1 (1), 74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Arias RJ; Welch EF; Blackburn NJ, New structures reveal flexible dynamics between the subdomains of peptidylglycine monooxygenase. Implications for an open to closed mechanism. Protein Sci 2023, 32 (4), e4615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Vendelboe TV; Harris P; Zhao Y; Walter TS; Harlos K; El Omari K; Christensen HE, The crystal structure of human dopamine b-hydroxylase at 2.9 Å resolution. Sci. Adv. 2016, 2 (4), E1500980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Erion MD; Tan J; Wong M; Jeng AY, Inhibition of peptidylglycine alpha-amidating monooxygenase by N-substituted homocysteine analogs. J. Med. Chem. 1994, 37 (26), 4430–7. [DOI] [PubMed] [Google Scholar]
- 31.Alwan KB; Welch EF; Arias RJ; Gambill BF; Blackburn NJ, Rational design of a histidine-methionine ste modeling the M-center of copper monooxygenases in a small metallochaperone scaffold. Biochemistry 2019, 58 (28), 3097–3108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Alwan KB; Welch EF; Blackburn NJ, Catalytic M center of copper monooxygenases probed by rational design. Effects of selenomethionine and histidine substitution on structure and reactivity. Biochemistry 2019, 58 (44), 4436–4446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Blackburn NJ; de Vries S; Barr ME; Houser RP; Tolman WB; Sanders D; Fee JA, X-ray Absorption studies on the mixed-valence and fully reduced forms of the soluble CuA domains of Thermus thermophilus and Bacillus subtilis cytochrome c oxidase: Structural evidence for minimal electron transfer reorganizational energy. J. Am. Chem. Soc. 1997, 119, 6135–6143. [Google Scholar]
- 34.Siluvai GS; Nakano M; Mayfield M; Blackburn NJ, The essential role of the Cu(II) state of Sco in the maturation of the Cu(A) center of cytochrome oxidase: evidence from H135Met and H135SeM variants of the Bacillus subtilis Sco. J. Biol. Inorg. Chem. 2011, 16, 285–287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Siluvai GS; Mayfield M; Nilges MJ; DeBeer George S; Blackburn NJ, Anatomy of a red copper center: Spectroscopic identification and reactivity of the copper centers of Bacillus subtilis Sco and Its Cys-to-Ala variants. J. Am. Chem. Soc. 2010, 132 (14), 5215–5226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Clark KM; Yu Y; van der Donk WA; Blackburn N; Lu Y, Modulating the Copper-Sulfur Interaction in Type 1 Blue Copper Azurin by Replacing Cys112 with Nonproteinogenic Homocysteine. Inorg. Chem. Front. 2014, 1 (2), 153–158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Additional intensity was found in the Fourier transform of the reduced WT protein in complex with the AAF-hCys inhibitor. This could be simulated by including a contribution from a weak scatterer at ~2.7 – 2.8 Å. Because the scattering is weak its origin is uncertain but it could be fit with N, O, or Cu (Table S2 fits 6, 7 and 8). While we have low confidence in this result, it is possibly the signature of a Cu-Cu interaction, or alternatively the presence of a second weakly coordinating ligand bridge. [Google Scholar]
- 38.Westmoreland TD; Wilcox DE; Baldwin MJ; Mims WB; Solomon EI, Detailed spectroscopic analysis of half-met hemocyanins: mixed-valent contributions to electronic properties and structure. J. Am. Chem. Soc. 1989, 111, 6106–6123. [Google Scholar]
- 39.Blackburn NJ; Barr ME; Woodruff WH; van der Oost J; de Vries S, Metal-metal bonding in biology: EXAFS evidence for a 2.5 Å copper-copper bond in the CuA center of cytochrome oxidase. Biochemistry 1994, 33 (34), 10401–10407. [DOI] [PubMed] [Google Scholar]
- 40.Blackburn NJ; de Vries S; Barr ME; Houser RP; Tolman WB; Sanders D; Fee JA, X-ray Absorption Studies on the Mixed-Valence and Fully Reduced Forms of the Soluble CuA Domains of Cytochrome c Oxidase. J. Am. Chem. Soc. 1997, 119 (Copyright (C) 2015. American Chemical Society (ACS). All Rights Reserved.), 6135–6143. [Google Scholar]
- 41.Farrar JA; Neese F; Lappalainen P; Kroneck PMH; Saraste M; Zumft WG; Thompson AJ, The electronic structure of CuA: A novel mixed-valence dinuclear copper electron transfer center. J. Am. Chem. Soc. 1996, 118, 11501–11514. [Google Scholar]
- 42.Kroneck PMH, Walking the seven lines: binuclear copper A in cytochrome c oxidase and nitrous oxide reductase. J. Biol. Inorg. Chem. 2018, 23 (1), 27–39. [DOI] [PubMed] [Google Scholar]
- 43.Gamelin DR; Randall DW; Hay MT; Houser RP; Mulder TC; Canters GW; de Vries S; Tolman WB; Lu Y; Solomon EI, Spectroscopy of mixed-valence CuA centers: ligand field control of ground state properties related to electron transfer. J. Am. Chem. Soc. 1998, 120, 5246–5263. [Google Scholar]
- 44.Williams KR; Gamelin DR; Lacroix LB; Houser RP; Tolman WB; Mulder MC; de Vries S; Hedman B; Hodgson KO; Solomon EI, The influence of copper-sulfur covalency and copper-copper bonding on valence delocalization and electron transfer in the CuA site of cytochrome c oxidase. J. Am. Chem. Soc. 1997, 119, 613–614. [Google Scholar]
- 45.Houser RP; Young VGJ; Tolman WB, A thiolate-bridged fully delocalized mixed-valence dicopper (I,II) complex that models the CuA biological electron-transfer site. J. Am. Chem. Soc. 1996, 118, 2101–2102. [Google Scholar]
- 46.One equivalent of peptide per protein is required to reduce one of the copper centers while a second is required to bind and form the thiolate bridged MV complex. However, this chemistry generates a disulfide species that is still capable of binding to the oxidized PHM through the interaction of its C-terminal carboxylate with R240/Y318 diad. This explains why a little over 2 equivalents of peptide are required to fully form the MV species, and why a third of the PHM remains unreactive since it is locked into an unreactive state by binding to the disulfide containing peptide. In the ascorbate reduced form, no thiol-disulfide conversion occurs so the peptide is expected to form a tight 1:1 complex. [Google Scholar]
- 47.Stoll S; Schweiger A, EasySpin, a comprehensive software package for spectral simulation and analysis in EPR. J. Magn. Reson. 2006, 178 (1), 42–55. [DOI] [PubMed] [Google Scholar]
- 48.Kaim W; Klein A; Glockle M, Exploration of mixed-valence chemistry: inventing new analogues of the Creutz-Taube ion. Acc. Chem. Res. 2000, 33 (11), 755–63. [DOI] [PubMed] [Google Scholar]
- 49.Williams PA; Blackburn NJ; Sanders D; Bellamy H; Stura EA; Fee JA; McRee DE, The CuA domain of Thermus thermophilus ba3- type cytochrome c oxidase at 1.6 Å resolution. Nat. Struct. Biol. 1999, 6, 509–516. [DOI] [PubMed] [Google Scholar]
- 50.Haltia T; Brown K; Tegoni M; Cambillau C; Saraste M; Mattila K; Djinovic-Carugo K, Crystal structure of nitrous oxide reductase from Paracoccus denitrificans at 1.6 A resolution. Biochem J 2003, 369 (Pt 1), 77–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Hay MT; Ang MC; Gamelin DR; Solomon EI; Antholine WE; Ralle M; Blackburn NJ; Massey PD; Wang X; Kwon AH; Lu Y, Spectroscopic characterization of an engineered purple CuA center in azurin. Inorg. Chem. 1998, 37, 191–198. [Google Scholar]
- 52.Robinson H; Ang MC; Gao Y-G; Hay MT; Lu Y; Wang AH-J, Structural basis of electron transfer modulation in the purple CuA center. Biochemistry 1999, 38, 5677–5683. [DOI] [PubMed] [Google Scholar]
- 53.Ross MO; Fisher OS; Morgada MN; Krzyaniak MD; Wasielewski MR; Vila AJ; Hoffman BM; Rosenzweig AC, Formation and Electronic Structure of an Atypical CuA Site. J. Am. Chem. Soc. 2019, 141 (11), 4678–4686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.We examined the EPR of the MV complex at room temperature but the spectrum was broadened to indetectability presumably due to fast relaxation. Thus we cannot rule out the possibility that the system becomes delocalized at RT similar to the behavior of the macrocyclic MV complex described by Gagne and coworkers: Gagne RR.; Koval CA.; Smith TJ.; Cimolino MC., J. Am. Chem. Soc. 1979, 101, 4571–4580. [Google Scholar]
- 55.Xie X; Gorelsky SI; Sarangi R; Garner DK; Hwang HJ; Hodgson KO; Hedman B; Lu Y; Solomon EI, Perturbations to the geometric and electronic structure of the CuA site: factors that influence delocalization and their contributions to electron transfer. J. Am. Chem. Soc. 2008, 130 (15), 5194–205. [DOI] [PubMed] [Google Scholar]
- 56.Chen P; Root DE; Campochiaro C; Fujisawa K; Solomon EI, Spectroscopic and electronic structure studies of the diamagnetic side-on CuII-superoxo complex Cu(O2)[HB(3-R-5-iPrpz)3]: antiferromagnetic coupling versus covalent delocalization. J. Am. Chem. Soc. 2003, 125 (2), 466–474. [DOI] [PubMed] [Google Scholar]
- 57.Lanci MP; Smirnov VV; Cramer CJ; Gauchenova EV; Sundermeyer J; Roth JP, Isotopic probing of molecular oxygen activation at copper(I) sites. J. Am. Chem. Soc. 2007, 129 (47), 14697–709. [DOI] [PubMed] [Google Scholar]
- 58.Maiti D; Fry HC; Woertink JS; Vance MA; Solomon EI; Karlin KD, A 1:1 copper-dioxygen adduct is an end-on bound superoxo copper(II) complex which undergoes oxygenation reactions with phenols. J. Am. Chem. Soc. 2007, 129 (2), 264–5. [DOI] [PubMed] [Google Scholar]
- 59.Woertink JS; Tian L; Maiti D; Lucas HR; Himes RA; Karlin KD; Neese F; Wurtele C; Holthausen MC; Bill E; Sundermeyer J; Schindler S; Solomon EI, Spectroscopic and computational studies of an end-on bound superoxo-Cu(II) complex: geometric and electronic factors that determine the ground state. Inorg. Chem. 2010, 49 (20), 9450–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Peterson RL; Himes RA; Kotani H; Suenobu T; Tian L; Siegler MA; Solomon EI; Fukuzumi S; Karlin KD, Cupric superoxo-mediated intermolecular C-H activation chemistry. J. Am. Chem. Soc. 2011, 133 (6), 1702–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Ginsbach JW; Peterson RL; Cowley RE; Karlin KD; Solomon EI, Correlation of the Electronic and Geometric Structures in Mononuclear Copper(II) Superoxide Complexes. Inorg. Chem. 2013, 52 (22), 12872–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Peterson RL; Ginsbach JW; Cowley RE; Qayyum MF; Himes RA; Siegler MA; Moore CD; Hedman B; Hodgson KO; Fukuzumi S; Solomon EI; Karlin KD, Stepwise Protonation and Electron-Transfer Reduction of a Primary Copper-Dioxygen Adduct. J. Am. Chem. Soc. 2013, 135 (44), 16454–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Tano T; Okubo Y; Kunishita A; Kubo M; Sugimoto H; Fujieda N; Ogura T; Itoh S, Redox properties of a mononuclear copper(II)-superoxide complex. Inorg. Chem. 2013, 52 (18), 10431–7. [DOI] [PubMed] [Google Scholar]
- 64.Kunishita A; Ertem MZ; Okubo Y; Tano T; Sugimoto H; Ohkubo K; Fujieda N; Fukuzumi S; Cramer CJ; Itoh S, Active site models for the Cu(A) site of peptidylglycine alpha-hydroxylating monooxygenase and dopamine beta-monooxygenase. Inorg. Chem. 2012, 51 (17), 9465–80. [DOI] [PubMed] [Google Scholar]
- 65.Kunishita A; Kubo M; Sugimoto H; Ogura T; Sato K; Takui T; Itoh S, Mononuclear Copper(II)-Superoxo Complexes that Mimic the Structure and Reactivity of the Active Centers of PHM and DbetaM. J. Am. Chem. Soc. 2009, 131, 2788–2789. [DOI] [PubMed] [Google Scholar]
- 66.Kim S; Lee JY; Cowley RE; Ginsbach JW; Siegler MA; Solomon EI; Karlin KD, A N3S(thioether)-Ligated Cu(II)-Superoxo with Enhanced Reactivity. J. Am. Chem. Soc. 2015, 137 (8), 2796–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Sanchez-Eguia BN; Flores-Alamo M; Orio M; Castillo I, Side-on cupric-superoxo triplet complexes as competent agents for H-abstraction relevant to the active site of PHM. Chem Commun (Camb) 2015, 51 (55), 11134–7. [DOI] [PubMed] [Google Scholar]
- 68.Kline CD; Blackburn NJ, Substrate-induced carbon monoxide reactivity suggests multiple enzyme conformations at the catalytic copper M-center of peptidylglycine monooxygenase. Biochemistry 2016, 55 (48), 6652–6661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Einarsdottir O; Killough PM; Fee JA; Woodruff WH, An infrared study of the binding and photodissociation of carbon monoxide in cytochrome ba3 from Thermus thermophilus. J. Biol. Chem 1989, 264 (5), 2405–8. [PubMed] [Google Scholar]
- 70.Bauman AT; Yukl ET; Alkevich K; McCormack AL; Blackburn NJ, The hydrogen peroxide reactivity of peptidylglycine monooxygenase supports a Cu(II)-superoxo catalytic intermediate. J. Biol. Chem. 2006, 281, 4190–4198. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
